205 related articles for article (PubMed ID: 11857638)
1. Binding interactions between peptides and proteins of the class II major histocompatibility complex.
McFarland BJ; Beeson C
Med Res Rev; 2002 Mar; 22(2):168-203. PubMed ID: 11857638
[TBL] [Abstract][Full Text] [Related]
2. Individual hydrogen bonds play a critical role in MHC class II: peptide interactions: implications for the dynamic aspects of class II trafficking and DM-mediated peptide exchange.
Sant AJ; Beeson C; McFarland B; Cao J; Ceman S; Bryant PW; Wu S
Immunol Rev; 1999 Dec; 172():239-53. PubMed ID: 10631950
[TBL] [Abstract][Full Text] [Related]
3. Enhanced catalytic action of HLA-DM on the exchange of peptides lacking backbone hydrogen bonds between their N-terminal region and the MHC class II alpha-chain.
Stratikos E; Wiley DC; Stern LJ
J Immunol; 2004 Jan; 172(2):1109-17. PubMed ID: 14707085
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen bond integrity between MHC class II molecules and bound peptide determines the intracellular fate of MHC class II molecules.
Arneson LS; Katz JF; Liu M; Sant AJ
J Immunol; 2001 Dec; 167(12):6939-46. PubMed ID: 11739513
[TBL] [Abstract][Full Text] [Related]
5. The relative energetic contributions of dominant P1 pocket versus hydrogen bonding interactions to peptide:class II stability: implications for the mechanism of DM function.
Bandyopadhyay A; Arneson L; Beeson C; Sant AJ
Mol Immunol; 2008 Mar; 45(5):1248-57. PubMed ID: 17980431
[TBL] [Abstract][Full Text] [Related]
6. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.
Busch R; Rinderknecht CH; Roh S; Lee AW; Harding JJ; Burster T; Hornell TM; Mellins ED
Immunol Rev; 2005 Oct; 207():242-60. PubMed ID: 16181341
[TBL] [Abstract][Full Text] [Related]
7. Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications.
Afridi S; Hoessli DC; Hameed MW
Immunol Rev; 2016 Jul; 272(1):151-68. PubMed ID: 27319349
[TBL] [Abstract][Full Text] [Related]
9. Disruption of hydrogen bonds between major histocompatibility complex class II and the peptide N-terminus is not sufficient to form a human leukocyte antigen-DM receptive state of major histocompatibility complex class II.
Schulze MS; Anders AK; Sethi DK; Call MJ
PLoS One; 2013; 8(7):e69228. PubMed ID: 23976922
[TBL] [Abstract][Full Text] [Related]
10. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules.
Kropshofer H; Hämmerling GJ; Vogt AB
Immunol Rev; 1999 Dec; 172():267-78. PubMed ID: 10631952
[TBL] [Abstract][Full Text] [Related]
11. HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes.
Narayan K; Chou CL; Kim A; Hartman IZ; Dalai S; Khoruzhenko S; Sadegh-Nasseri S
Nat Immunol; 2007 Jan; 8(1):92-100. PubMed ID: 17143275
[TBL] [Abstract][Full Text] [Related]
12. Energetics and cooperativity of the hydrogen bonding and anchor interactions that bind peptides to MHC class II protein.
McFarland BJ; Katz JF; Sant AJ; Beeson C
J Mol Biol; 2005 Jul; 350(1):170-83. PubMed ID: 15921691
[TBL] [Abstract][Full Text] [Related]
13. Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing.
Zhou Z; Reyes-Vargas E; Escobar H; Chang KY; Barker AP; Rockwood AL; Delgado JC; He X; Jensen PE
Eur J Immunol; 2017 Feb; 47(2):314-326. PubMed ID: 27861808
[TBL] [Abstract][Full Text] [Related]
14. The Utility of Supertype Clustering in Prediction for Class II MHC-Peptide Binding.
Shen WJ; Zhang X; Zhang S; Liu C; Cui W
Molecules; 2018 Nov; 23(11):. PubMed ID: 30463372
[TBL] [Abstract][Full Text] [Related]
15. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
[TBL] [Abstract][Full Text] [Related]
16. Structural factors contributing to DM susceptibility of MHC class II/peptide complexes.
Belmares MP; Busch R; Wucherpfennig KW; McConnell HM; Mellins ED
J Immunol; 2002 Nov; 169(9):5109-17. PubMed ID: 12391227
[TBL] [Abstract][Full Text] [Related]
17. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes.
Schafer PH; Green JM; Malapati S; Gu L; Pierce SK
J Immunol; 1996 Dec; 157(12):5487-95. PubMed ID: 8955198
[TBL] [Abstract][Full Text] [Related]
18. Ligand exchange of major histocompatibility complex class II proteins is triggered by H-bond donor groups of small molecules.
Falk K; Lau JM; Santambrogio L; Esteban VM; Puentes F; Rotzschke O; Strominger JL
J Biol Chem; 2002 Jan; 277(4):2709-15. PubMed ID: 11602608
[TBL] [Abstract][Full Text] [Related]
19. Dissection of the HLA-DR4 peptide repertoire in endocrine epithelial cells: strong influence of invariant chain and HLA-DM expression on the nature of ligands.
Muntasell A; Carrascal M; Alvarez I; Serradell L; van Veelen P; Verreck FA; Koning F; Abian J; Jaraquemada D
J Immunol; 2004 Jul; 173(2):1085-93. PubMed ID: 15240697
[TBL] [Abstract][Full Text] [Related]
20. Point mutations in or near the antigen-binding groove of HLA-DR3 implicate class II-associated invariant chain peptide affinity as a constraint on MHC class II polymorphism.
Doebele RC; Pashine A; Liu W; Zaller DM; Belmares M; Busch R; Mellins ED
J Immunol; 2003 May; 170(9):4683-92. PubMed ID: 12707347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
